SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000431
Filing Date
2021-10-19
Accepted
2021-10-19 09:30:59
Documents
13
Period of Report
2021-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp101821form8k.htm   iXBRL 8-K 22468
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 16805
  Complete submission text file 0001607062-21-000431.txt   207272

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rgbp-20211018.xsd EX-101.SCH 3052
4 XBRL LABEL FILE rgbp-20211018_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE rgbp-20211018_pre.xml EX-101.PRE 22377
6 EXTRACTED XBRL INSTANCE DOCUMENT rgbp101821form8k_htm.xml XML 3452
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 211329781
SIC: 2834 Pharmaceutical Preparations